Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness(Oncogene, 10.1038/sj.onc.1207775);Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness

Oncogene

Volumn 23, Issue 34, 2004, Pages 5834-5842

  Duxbury, Mark S ^a   Ito, Hiromichi ^a   Benoit, Eric ^a   Zinner, Michael J ^a   Ashley, Stanley W ^a   Whang, Edward E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Akt; Cancer; CEACAM6; IGF I invasion; Insulin like growth factor I; MMP 2; Pancreatic adenocarcinoma; Src

Indexed keywords

ANTIBODY; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; GELATINASE A; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CARCINOMA CELL; CELL CLONE; CELL FUNCTION; CELL INVASION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE SRC; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 4143071356     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-023-02784-6     Document Type: Erratum

References (58)

1. Baserga R, Hongo A, Rubini M, Prisco M and Valentinis B. (1997). Biochim. Biophys. Acta, 1332, F105-F126.
2. Baserga R, Sell C, Porcu P and Rubini M. (1994). Cell Prolif., 27, 63-71.
3. Bergmann U, Funatomi H, Yokoyama M, Beger HG and Korc M. (1995). Cancer Res., 55, 2007-2011.
4. Berrozpe G, Schaeffer J, Peinado MA, Real FX and Perucho M. (1994). Int. J. Cancer, 58, 185-191.
5. Brodt P, Fallavollita L, Khatib AM, Samani AA and Zhang D. (2001). J. Biol. Chem., 276, 33608-33615.
6. Burfeind P, Chernicky CL, Rininsland F, Ilan J and Ilan J. (1996). Proc. Natl. Acad. Sci. USA, 93, 7263-7268.
7. Datta K, Nambudripad R, Pal S, Zhou M, Cohen HT and Mukhopadhyay D. (2000). J. Biol. Chem., 275, 20700-20706.
8. Downward J. (1998). Curr. Opin. Cell Biol., 10, 262-267.
9. Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, Baserga R and Barrett JC. (1998). Cancer Res., 58, 3353-3361.
10. Duxbury MS, Ito H, Zinner MJ, Ashley SW and Whang EE. (2004). Oncogene, 23, 465-473.
11. Ellenrieder V, Adler G and Gress TM. (1999). Ann. Oncol., 10 (Suppl 4), 46-50.
12. Flossmann-Kast BB, Jehle PM, Hoeflich A, Adler G and Lutz MP. (1998). Cancer Res., 58, 3551-3554.
13. Gardner-Thorpe J, Ito H, Ashley SW and Whang EE. (2002). Biochem. Biophys. Res. Commun., 293, 391-395.
14. Guirouilh J, Castroviejo M, Balabaud C, Desmouliere A and Rosenbaum J. (2000). Int. J. Oncol., 17, 777-781.
15. Hasegawa T, Isobe K, Tsuchiya Y, Oikawa S, Nakazato H, Nakashima I and Shimokata K. (1993). Br. J. Cancer, 67, 58-65.
16. Ilantzis C, DeMarte L, Screaton RA and Stanners CP. (2002). Neoplasia, 4, 151-163.
17. Ito H, Gardner-Thorpe J, Zinner MJ, Ashley SW and Whang EE. (2003). Surgery, 134, 221-226.
18. Jiang T and Qiu Y. (2003). J. Biol. Chem., 278, 15789-15793.
19. Kaleko M, Rutter WJ and Miller AD. (1990). Mol. Cell. Biol., 10, 464-473.
20. Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele HG, Honold G, Pantel K and Riethmuller G. (1993). Oncogene, 8, 289-298.
21. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW and Martin GR. (1986). Biochemistry, 25, 312-318.
22. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K and Martin GR. (1982). Biochemistry, 21, 6188-6193.
23. Kodera Y, Isobe K, Yamauchi M, Satta T, Hasegawa T, Oikawa S, Kondoh K, Akiyama S, Itoh K and Nakashima I. (1993). Br. J. Cancer, 68, 130-136.
24. Kuroki M, Abe H, Imakiirei T, Liao S, Uchida H, Yamauchi Y, Oikawa S and Kuroki M. (2001). J. Leukoc. Biol., 70, 543-550.
25. Lazar-Molnar E, Hegyesi H, Toth S and Falus A. (2000). Cytokine, 12, 547-554.
26. Li SL, Liang SJ, Guo N, Wu AM and Fujita-Yamaguchi Y. (2000). Cancer Immunol. Immunother., 49, 243-252.
27. Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maillet B and Kloppel G. (1994). Br. J. Cancer, 69, 144-151.
28. Long L, Navab R and Brodt P. (1998a). Cancer Res., 58, 3243-3247.
29. Long L, Nip J and Brodt P. (1994). Cancer Res., 54, 3732-3737.
30. Long L, Rubin R and Brodt P. (1998b). Exp. Cell Res., 238, 116-121.
31. Macaulay VM. (1992). Br. J. Cancer, 65, 311-320.
32. Mayne KM, Pulford K, Jones M, Micklem K, Nagel G, van der School CE and Mason DY. (1993). Br. J. Haematol., 83, 30-38.
33. Mira E, Manes S, Lacalle RA, Marquez G and Martinez A. (1999). Endocrinology, 140, 1657-1664.
34. Murphy LO, Cluck MW, Lovas S, Otvos F, Murphy RF, Schally AV, Permert J, Larsson J, Knezetic JA and Adrian TE. (2001). Br. J. Cancer, 84, 926-935.
35. Naumann M, Savitskaia N, Eilert C, Schramm A, Kalthoff H and Schmiegel W. (1996). Gastroenterology, 110, 1215-1224.
36. Ordonez C, Screaton RA, Ilantzis C and Stanners CP. (2000). Cancer Res., 60, 3419-3424.
37. Ouban A, Muraca P, Yeatman T and Coppola D. (2003). Hum. Pathol., 34, 803-808.
38. Park BK, Zeng X and Glazer RI. (2001). Cancer Res., 61, 7647-7653.
39. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D and Baserga R. (1993). Cancer Res., 53, 1102-1106.
40. Frisco M, Hongo A, Rizzo MG, Sacchi A and Baserga R. (1997). Mol. Cell. Biol., 17, 1084-1092.
41. Raitano AB, Scuderi P and Korc M. (1990). Pancreas, 5, 267-277.
42. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R and Rubin R. (1994). Cancer Res., 54, 2218-2222.
43. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B and Thompson J. (2000). Am. J. Pathol., 156, 595-605.
44. Sell C, Baserga R and Rubin R. (1995). Cancer Res., 55, 303-306.
45. Shanmugathasan M and Jothy S. (2000). Pathol. Int., 50, 273-279.
46. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M and Kloppel G. (2003). Virchows Arch., 442, 444-452.
47. Skubitz KM, Campbell KD, Ahmed K and Skubitz AP. (1995). J. Immunol., 155, 5382-5390.
48. Sonenberg N and Gingras AC. (1998). Curr. Opin. Cell Biol., 10, 268-275.
49. Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA and Schiffmann E. (1989). J. Biol. Chem., 264, 21544-21549.
50. Streuli CH and Gilmore AP. (1999). J. Mammary. Gland. Biol. Neoplasia, 4, 183-191.
51. Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH and Testa JR. (2001). Cancer Res., 61, 589-593.
52. Tooze JA, Saso R, Marsh JC, Papadopoulos A, Pulford K and Gordon-Smith EC. (1995). Exp. Hematol., 23, 1484-1491.
53. Wu Y, Tewari M, Cui S and Rubin R. (1996). J. Cell Physiol, 168, 499-509.
54. Wu Y, Yakar S, Zhao L, Hennighausen L and LeRoith D. (2002). Cancer Res., 62, 1030-1035.
55. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC and Imai K. (1998). Oncogene, 16, 2681-2686.
56. Yoon A and Hurta RA. (2001). Mol. Cell. Biochem., 223, 1-6.
57. Zeng H, Datta K, Neid M, Li J, Parangi S and Mukhopadhyay D. (2003). Biochem. Biophys. Res. Commun., 302, 46-55.
58. Zhang D and Brodt P. (2003). Oncogene, 22, 974-982.